4//SEC Filing
Parker Albert P 4
Accession 0001062993-23-004049
CIK 0001621443other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:21 PM ET
Size
4.9 KB
Accession
0001062993-23-004049
Insider Transaction Report
Form 4
Parker Albert P
Chief Legal Officer
Transactions
- Sale
Common Stock
2023-02-15$0.54/sh−3,173$1,719→ 227,018 total
Footnotes (1)
- [F1]This transaction represents shares required to be sold by the Reporting Person to satisfy tax obligations and certain equity plan administrator fees in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001750079
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:21 PM ET
- Size
- 4.9 KB